Last reviewed · How we verify
headache — Treatment Landscape & Competitive Intelligence
6 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Excedrin Extra Strength Pain Reliever | NSAID | Haleon Us Holdings | Nonsteroidal Anti-inflammatory Drug [EPC] | Cyclooxygenase | 2004-01-01 | |
| Immune Support | CORTISONE | Merck | Non-Standardized Plant Allergenic Extract [EPC] | 1974-01-01 | ||
| Addiclenz | ASPARTAME | Deseret Biologicals, Inc. | Standardized Chemical Allergen [EPC] | |||
| MEDIQUE APAP EXTRA STRENGTH acetaminophen tablet, film coated | APAP | HF Acquisition Co LLC, DBA HealthFirst | ||||
| Dmae 1549 | DMAE | Professional Complementary Health Formulas | ||||
| Aspartame/MSG Detox | MALTODEXTRIN | Deseret Biologicals, Inc. | Standardized Chemical Allergen [EPC] |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Deseret Biologicals, Inc. · 2 drugs in headache
- HF Acquisition Co LLC, DBA HealthFirst · 1 drug in headache
- Haleon Us Holdings · 1 drug in headache
- Merck · 1 drug in headache
- Professional Complementary Health Formulas · 1 drug in headache
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in headache:
- headache treatment updates — RSS
- headache treatment updates — Atom
- headache treatment updates — JSON
Cite this brief
Drug Landscape (2026). headache — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/headache. Accessed 2026-06-10.
Related
- headache full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing